← FDA Drug Approvals (Drugs@FDA)

RASAGILINE MESYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2019-10-04

Drug application

FDA Application #

ANDA206153

Application type

Abbreviated New Drug Application (Generic)

Brand name

RASAGILINE MESYLATE

Generic name

RASAGILINE MESYLATE

Active ingredients

RASAGILINE MESYLATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

REGCON HOLDINGS

Manufacturer

Avet Pharmaceuticals Inc.

First approval

2019-10-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown